Assessment of human epidermal growth factor receptor 2 status in urothelial carcinoma of the upper urinary tract: A study using dual-color in situ hybridization and immunohistochemistry

Applied Immunohistochemistry and Molecular Morphology

Volumn 20, Issue 4, 2012, Pages 363-366

  Vershasselt Crinquette, Marie ^a   Colin, Pierre ^b   Ouzzane, Adil ^b   Gnemmi, Viviane ^a   Robin, Yves Marie ^c   Aubert, Sebastien ^a   Villers, Arnauld ^b   Leroy, Xavier ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c Department of Pathology   (France)

Author keywords

amplification; HER2; in situ hybridization; upper urinary tract; urothelial carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; DUAL COLOR IN SITU HYBRIDIZATION; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOPLASM STAGING; RECEPTOR, ERBB-2; RECURRENCE; SURVIVAL ANALYSIS; UP-REGULATION; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84862859206     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318241cab9     Document Type: Article

References (23)

1. Roupret M, Ziguener R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584-594.
2. Olgac S, Mazumdar M, Dalbagni G, et al. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol. 2004;28:1545-1552. (Pubitemid 39564958)
3. Perez-Montiel D, Wakely PE, Hes O, et al. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol. 2006;19:494-503.
4. Roupret M, Yates DR, Comperat E, et al. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum. Eur Urol. 2008;54:1226-1236.
5. Audenet F, Yates DR, Cussenot O, et al. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract. Urol Oncol. 2010;28. (In press).
6. Lordick F. Trastuzumab: a new treatment option for HER2-positive metastatic gastric and gastrooesophageal junction cancer. Future Oncol. 2011;7:187-199.
7. Albarello L, Pecciarini L, Doglioni C. HER2 testing in gastric cancer. Adv Anat Pathol. 2011;18:53-59.
8. Guttierez C, Schiff R. HER2: biology, detection, and clinical implications. Arch Pathol Lab Med. 2011;135:55-62.
9. Latif Z, Watters AD, Dunn I, et al. HER2/Neu gene amplification and protein overexpression in G3pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy? Eur J Cancer. 2004; 40:56-63. (Pubitemid 37542318)
10. Coogan CL, Estrada CR, Kapur S, et al. HER2/Neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder. Urology. 2004;63:786-790. (Pubitemid 38479440)
11. Jimenez RE, Hussain M, Blanco FJ, et al. HER-2/Neu over-expression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors. Clin Cancer Res. 2001;7:2440-2447. (Pubitemid 32751647)
12. Lae M, Couturier J, Oudard S, et al. Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients. Ann Oncol. 2010;21:815-819.
13. Langner C, Gross C, Rehak P, et al. HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique. Urology. 2005;65:176-180. (Pubitemid 40169640)
14. Lopez-Beltran A, Sauter G, Gasser T. Tumors of the urinary system: infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, eds. World Health Organization Classification of Tumours-Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004:93-109.
15. Wolff AC, Hammond EH, Schwartz JN, et al. American Society of Clinical Oncology: College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118-145. (Pubitemid 350003059)
16. Bartlett JMS, Campbell FM, Ibrahim M, et al. A UK NEQAS ISH multicenter ring study using the ventana HER2 dual-color ISH assay. Am J Clin Pathol. 2011;135:157-162.
17. Tapia C, Glatz K, Novotny H, et al. Close association between HER-2 amplification and overexpression in human tumors of non breast origin. Mod Pathol. 2007;20:192-198. (Pubitemid 46422173)
18. Ching CB, Amin MB, Tubbs RR, et al. HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridisation. Mod Pathol. 2011;24:1111-1119.
19. Izquierdo L, Mengual L, Gazquez C, et al. Molecular characterization of upper urinary tract tumours. BJU Int. 2009;106: 868-872.
20. Marin AP, Arranz EE, Sanchez AR, et al. Role of anti-HER-2 therapy in bladder carcinoma. J Cancer Res Clin Oncol. 2010; 136:1915-1920.
21. Peyromaure M, Scotte F, Amsellen-Ouzana D, et al. Trastuzumab in metastatic transitional cell carcinoma of the urinary tract: report on six patients. Eur Urol. 2005;48:771-778.
22. Hussain MHA, Mac Vicar GR, Petrylak DP, et al. Trastuzumab, paclitaxel, carboplatin and gemtacibine in advanced human epidermal growth factor receptor-2/neu positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial. J Clin Oncol. 2007;25:2218-2224. (Pubitemid 46954646)
23. Simonetti S, Russo R, Ciancia G, et al. Role of polysomy 17 intransitional cell carcinoma of the bladder: immunohistochemical study of HER2/Neu expression and FISH analysis of c-erB-2 gene and chromosome 17. Int J Surg Pathol. 2009;17:198-205.